Systemic-to-Pulmonary Artery Shunt Thromboprophylaxis: Searching for the Holy Grail*

1 Pediatric Cardiology/Pediatric Critical Care, University of Arkansas for Medical Sciences, Little Rock, AR

2 Pediatric Cardiothoracic Surgery, University of Arkansas for Medical Sciences, Little Rock, AR

3 Pediatric Critical Care/Pediatric Hematology-Oncology, University of Minnesota, Minneapolis, MN

*See also p. 727.

Dr. Steiner’s institution received funding from the Department of Defense; she received funding from Octapharma and HealthCore/New England Research Institute; she disclosed that she is on the Octapharma advisory board and an Infant Jarvik Data Safety Monitoring Board Department of Defense contract; she disclosed the off-label product use of Clopidogrel. The remaining authors have disclosed that they do not have any potential conflicts of interest.

留言 (0)

沒有登入
gif